Ads
related to: depo provera minimum interval- Prescribing Information
View Prescribing Information For A
Low-Dose Oral Contraceptive.
- Safety Information
Find Important Safety Information
For A Low-Dose Oral Contraceptive.
- Resources For Your Office
Visit To Find HCP Resources
For Your Practice.
- Efficacy & Safety Data
View Efficacy & Safety Data
For A Low-Dose Oral Contraceptive.
- Prescribing Information
Search results
Results From The WOW.Com Content Network
Medroxyprogesterone acetate (brand names Depo-Provera, Provera, Depo-subQ Provera 104) [4] – 150 mg (intramuscularly) or 104 mg (subcutaneously) every 3 months [3] Norethisterone enanthate (brand names NET EN, Noristerat, Norigest, Doryxas) [ 5 ] – 200 mg (intramuscularly) every 2 months [ 3 ]
Depo-Provera, Depo-SubQ Provera 104, others: AHFS/Drugs.com: depo-provera: Failure rates (first year) Perfect use: 0.2% [37] Typical use: 6% [37] Usage; Duration effect: 3 months (12–14 weeks) Reversibility: 3–18 months: User reminders: Maximum interval is just under 3 months: Clinic review: 12 weeks: Advantages and disadvantages; STI ...
CICs are different from progestogen-only injectable contraceptives (POICs), such as depot medroxyprogesterone acetate (DMPA; brand names Depo-Provera, Depo-SubQ Provera 104) and norethisterone enantate (NETE; brand name Noristerat), which are not combined with an estrogen and are given once every two to three months instead of once a month. [2]
Depot MPA (DMPA) and EC/MPA were developed by Upjohn in the 1960s. [12] [13] DMPA (brand name Depo-Provera) was introduced for use as a progestogen-only injectable contraceptive for the first time outside of the United States in 1969 and was subsequently approved for use in birth control in the United States in 1992.
Provera: Progestogen: Oral: 2.5–40 mg/day Depo-Provera: Progestogen: IM: 150 mg every 3 mos: Depo-SubQ Provera 104: Progestogen: SC: 104 mg every 3 mos ...
Medroxyprogesterone, also known as 6α-methyl-17α-hydroxyprogesterone or as 6α-methyl-17α-hydroxypregn-4-en-3,20-dione, is a synthetic pregnane steroid and a derivative of progesterone.
The Pearl Index, also called the Pearl rate, is the most common technique used in clinical trials for reporting the effectiveness of a birth control method. It is a very approximate measure of the number of unintended pregnancies in 100 woman-years of exposure that is simple to calculate, but has a number of methodological deficiencies.
Depot medroxyprogesterone acetate, a birth control medication marketed under the brand name Depo-Provera; 2,2-Dimethoxy-2-phenylacetophenone, a radical initiator; N,N′-Dimethyl-1,3-propanediamine, a cross linking reagent; Dimethylol propionic acid; Des Moines Performing Arts, the organization that operates the Civic Center of Greater Des Moines